Second primary cancers in patients with hepatocellular carcinoma: A nationwide cohort study in Taiwan

Liver International

Volumn 33, Issue 4, 2013, Pages 616-623

  Wu, Wen Chieh ^a   Chen, Yung Tai ^a,b   Hwang, Chian Yaw ^a,c   Su, Chien Wei ^a,c   Li, Szu Yuan ^a,c   Chen, Tzeng Ji ^a,c   Liu, Chia Jen ^a,c   Kao, Wei Yu ^a,c   Chao, Yee ^a,c   Lin, Han Chieh ^a,c   Wu, Jaw Ching ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Hepatocellular carcinoma; Multiple primary malignancy; Second primary cancer

Indexed keywords

ADULT; ARTICLE; BILE DUCT CANCER; BLADDER CANCER; BONE CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVOR; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIMARY TUMOR; SECOND CANCER; SEX DIFFERENCE; SOFT TISSUE CANCER; STOMACH CANCER; TAIWAN;

AGE FACTORS; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TAIWAN;

EID: 84875047227     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12103     Document Type: Article

References (41)

1. Schottenfeld D, Berg JW, Vitsky B. Incidence of multiple primary cancers. II. Index cancers arising in the stomach and lower digestive system. J Natl Cancer Inst 1969; 43: 77-86.
2. Liu H, Hemminki K, Sundquist J. Renal cell carcinoma as first and second primary cancer: etiological clues from the Swedish family-cancer database. J Urol 2011; 185: 2045-9.
3. Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol 2003; 26: 79-83.
4. Schoenberg BS, Greenberg RA, Eisenberg H. Occurrence of certain multiple primary cancers in females. J Natl Cancer Inst 1969; 43: 15-32.
5. Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-74.
6. Hung HH, Chiou YY, Hsia CY, et al. Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 2011; 9: 79-86.
7. Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE. Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology 2012; 55: 476-82.
8. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752-63.
9. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008; 48(Suppl 1.): S20-37.
10. Riesz T, Jako JM, Juhasz J. Secondary malignant tumors accompanied by primary hepatocellular carcinoma. Acta Hepatogastroenterol (Stuttg) 1979; 26: 364-7.
11. Koide N, Hanazaki K, Fujimori Y, et al. Synchronous gastric cancer associated with hepatocellular carcinoma: a study of 10 patients. Hepatogastroenterology 1999; 46: 3008-14.
12. Onitsuka A, Hirose H, Ozeki Y, et al. Clinical study on hepatocellular carcinoma with extrahepatic malignancies. Int Surg 1995; 80: 128-30.
13. Lin DY, Liaw YF, Wu CS, et al. Hepatocellular carcinoma associated with second primary malignancy. Liver 1987; 7: 106-9.
14. Takayasu K, Kasugai H, Ikeya S, et al. A clinical and radiologic study of primary liver cancer associated with extrahepatic primary cancer. Cancer 1992; 69: 45-51.
15. Shimada M, Takenaka K, Fujiwara Y, et al. Characteristics of hepatocellular carcinoma associated with extrahepatic primary malignancies in southern Japan. Am J Gastroenterol 1996; 91: 754-8.
16. Kanematsu M, Imaeda T, Yamawaki Y, et al. Hepatocellular carcinoma with extrahepatic primary neoplasms. Gastrointest Radiol 1992; 17: 53-7.
17. Lai CR, Liu HC. Hepatocellular carcinoma coexisted with second malignancy-a study of 13 cases from a consecutive 440 autopsy cases of HCC. Zhonghua Yi Xue Za Zhi (Taipei) 1990; 46: 202-7.
18. Wong LL, Lurie F, Takanishi DM Jr. Other primary neoplasms in patients with hepatocellular cancer: prognostic implications? Hawaii Med J 2007; 66: 204, 206-8.
19. Bruno G, Andreozzi P, Graf U, Santangelo G. Virus: a high risk factor for a second primary malignancy besides hepatocellular carcinoma. Fact or fiction? Clin Ter 1999; 150: 413-18.
20. de Pangher Manzini V, Calucci F, Terpin MM, et al. Multiple primary malignant tumors in patients with hepatocellular carcinoma. A review of 29 patients. Tumori 1996; 82: 245-8.
21. Nzeako UC, Goodman ZD, Ishak KG. Association of hepatocellular carcinoma in North American patients with extrahepatic primary malignancies. Cancer 1994; 74: 2765-71.
22. Fernandez-Ruiz M, Guerra-Vales JM, Castelbon-Fernandez FJ, et al. Multiple primary malignancies in Spanish patients with hepatocellular carcinoma: analysis of a hospital-based tumor registry. J Gastroenterol Hepatol 2009; 24: 1424-30.
23. Di Stasi M, Sbolli G, Fornari F, et al. Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors. Oncology 1994; 51: 459-64.
24. Cheng TM. Taiwan's new national health insurance program: genesis and experience so far. Health Aff 2003; 22: 61-76.
25. National health insurance research database, Taiwan Available at: http://w3.nhri.org.tw/nhird/en/index.htm. Accessed March 30, 2012.
26. Kao WY, Hwang CY, Chang YT, et al. Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study. Aliment Pharmacol Ther 2012; 36: 467-76.
27. Lai SW, Chen PC, Liao KF, et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol 2012; 107: 46-52.
28. Luo JC, Leu HB, Huang KW, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. Can Med Assoc J 2011; 183: E1345-51.
29. Krueger H, McLean D, Williams D. Meaning of SPC. Prog Exp Tumor Res 2008; 40: 7-16.
30. Dong C, Hemminki K. Second primary neoplasms in 633, 964 cancer patients in Sweden, 1958-1996. Int J Cancer 2001; 93: 155-61.
31. Hisada M, Chen BE, Jaffe ES, Travis LB. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. J Natl Cancer Inst 2007; 99: 215-22.
32. Ogle KS, Swanson GM, Woods N, Azzouz F. Cancer and comorbidity: redefining chronic diseases. Cancer 2000; 88: 653-63.
33. Win AK, Young JP, Lindor NM, et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol 2012; 30: 958-64.
34. Schuz J, Jacobsen R, Olsen JH, et al. Cellular telephone use and cancer risk: update of a nationwide Danish cohort. J Natl Cancer Inst 2006; 98: 1707-13.
35. Kim HT. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 2007; 13: 559-65.
36. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Amer Statist Assoc 1999; 94: 496-509.
37. Becker U, Tonnesen H, Kaas-Claesson N, Gluud C. Menstrual disturbances and fertility in chronic alcoholic women. Drug Alcohol Depend 1989; 24: 75-82.
38. Sorensen HT, Friis S, Olsen JH, et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 1998; 28: 921-5.
39. Arase Y, Kobayashi M, Suzuki F, et al. Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients. Hepatol Res 2012; 42: 264-72.
40. Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol 2010; 23: 253-62.
41. Wong G, Hayen A, Chapman JR, et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol 2009; 20: 1341-50.